Acalabrutinib
Zanubrutinib
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
NCCN COVID-19 Resources Page
Leukemia & Lymphoma Society
Patient Power
ASH: COVID-19 Resources for Managing Blood Cancers